buying digital currency, See results about

The contracted sales of Xuhui Holding Group in November was 2.27 billion yuan, a year-on-year decrease of 41%.Minister of Malaysia: ZTE will invest 200 million ringgit in Malaysia.Research Report: In the third quarter, the installed capacity of traction inverters for electric vehicles in China accounted for 61% of the world. According to the latest research of TrendForce Jibang Consulting, the total installed capacity of traction inverters for electric vehicles in the third quarter of 2024 reached 6.87 million, which was 7% higher than that in the same period last year, but the growth rate has been reduced. In the competition pattern of first-class suppliers, BYD benefited from the hot sales of its models. In the third quarter, the installed market share of traction inverter increased by 1% to 18%, surpassing Denso of Japanese factory for the first time and becoming the company with the highest market share. The market share of Huichuan Technology has also increased to 6%, which shows that the competitiveness of China manufacturers in this field continues to increase. Generally speaking, China manufacturers, Japanese manufacturers and Tesla together account for half of the global installed capacity, while the influence of European and American manufacturers is gradually weakening. TrendForce Jibang Consulting indicated that the regional differentiation of traction inverters is becoming more and more obvious, with the installed capacity in China accounting for 61% of the global total. Under the pressure of shrinking market, Europe is actively reforming and cutting expenditure to enhance the competitiveness of the electric vehicle industry chain. In the short term, the stable demand in China market will continue to support the growth of traction inverter market. In the long run, if the European automobile industry chain can be successfully reformed, it will help boost the overall performance of the global traction inverter and electric vehicle market.

Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Sources: Boeing restarted the production of 737 MAX last week. Sources said that about one month after the strike ended, Boeing restarted the production of 737 MAX aircraft last week.Baiao Intelligent: Cancel the absorption and merger of wholly-owned subsidiaries. Baiao Intelligent announced on December 10 that the company intends to cancel the absorption and merger of wholly-owned subsidiaries Kunshan Baisente Materials and Materials Co., Ltd. and Kunshan Baiao Intelligent Logistics Co., Ltd. in consideration of the actual operation and business development plan of the company. This termination will not lead to changes in the scope of the company's merger, the actual rights and interests held by the company will not change, it will not adversely affect the company's production and operation, and there will be no harm to the interests of the company and shareholders.

With the return of high dividend assets, the market pays attention to the investment value of dividend sector. The Standard & Poor's dividend ETF(562060) rose by 1.07% at midday. By midday on December 10th, the standard & poor's dividend ETF(562060) rose by 1.07%, with a turnover of 20,646,600 yuan. The constituent stocks rose strongly, with Yongxing Materials rising by 3.73%, Aopu Technology rising by 2.12%, Lu 'an Huaneng rising by 2%, Gaoce shares and Jianfa shares rising one after another. In the news, recently, the strong performance of China bond market led to the decline of the yield of 10-year treasury bonds, which fell below the key point of 2.0%, and the dividend assets in the A-share market ushered in an upward trend. Insiders pointed out that the decline in the cost performance of bond allocation is a long-term dimensional reason for supporting the dominance of the dividend sector. With the continuous decline of the yield of 10-year treasury bonds, institutional investors' confirmation of the long-term low interest rate environment will be conducive to the continuous excavation of the value of dividend assets.Heavy meeting set the tone! The turnover of A-shares exceeded one trillion yuan for 50 consecutive trading days, focusing on the opportunities of core assets of A50ETF Huabao (159596). On December 10th, the A-share market rose across the board, and the turnover of Shanghai and Shenzhen stock markets exceeded one trillion yuan for the 50th consecutive trading day, setting a new record. By midday, A50ETF Huabao (159596) had increased by 1.98%, with a turnover of 101 million yuan. In terms of constituent stocks, the top ten awkward stocks rose more and fell less. CITIC Securities led the gains, and China Ping An, China Merchants Bank and other stocks followed suit. According to changjiang securities's analysis, "moderately loose monetary policy" indicates abundant liquidity and broad-spectrum interest rate is still in the downward channel, which is expected to benefit bonds and stocks from the denominator. The "more active fiscal policy" and "all-round expansion of domestic demand" indicate that the broad credit policy is expected to continue to increase, and it is expected to support the price of equity assets from the molecular side.This round of Palestinian-Israeli conflict has killed 44,758 people in the Gaza. According to a statement issued by the health department in Gaza on December 10th, local time, since the new round of Palestinian-Israeli conflict broke out on October 7th last year, Israeli military operations in Gaza have killed 44,758 Palestinians and injured 106,134 others.